You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Aminocaproic acid - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for aminocaproic acid and what is the scope of patent protection?

Aminocaproic acid is the generic ingredient in four branded drugs marketed by Epic Pharma Llc, Abraxis Pharm, Baxter Hlthcare, Hospira, Luitpold, Hikma, Amneal, Annora Pharma, Aurobindo Pharma, Belcher, Carnegie, Florida, Sunny, Taro, Tulex Pharms Inc, Vistapharm, Ani Pharms, Edenbridge Pharms, MSN, and Optimus, and is included in twenty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for aminocaproic acid. Twenty-one suppliers are listed for this compound.

Summary for aminocaproic acid

US Patents:	0
Tradenames:	4
Applicants:	20
NDAs:	27
Drug Master File Entries:	6
Finished Product Suppliers / Packagers:	21
Raw Ingredient (Bulk) Api Vendors:	183
Clinical Trials:	37
Patent Applications:	9,354
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for aminocaproic acid
What excipients (inactive ingredients) are in aminocaproic acid?	aminocaproic acid excipients list
DailyMed Link:	aminocaproic acid at DailyMed

See drug prices for aminocaproic acid

Recent Clinical Trials for aminocaproic acid

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Minia University	Phase 3
NYU Langone Health	N/A
Assiut University	Phase 4

See all aminocaproic acid clinical trials

Pharmacology for aminocaproic acid

Drug Class	Antifibrinolytic Agent
Physiological Effect	Decreased Fibrinolysis

Medical Subject Heading (MeSH) Categories for aminocaproic acid

Antifibrinolytic Agents

US Patents and Regulatory Information for aminocaproic acid

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Belcher	AMINOCAPROIC ACID	aminocaproic acid	SOLUTION;ORAL	213825-001	Apr 8, 2021	AA	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Optimus	AMINOCAPROIC ACID	aminocaproic acid	TABLET;ORAL	213944-001	Sep 14, 2022	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Ani Pharms	AMINOCAPROIC ACID	aminocaproic acid	TABLET;ORAL	211629-001	Dec 14, 2020	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Sunny	AMINOCAPROIC ACID	aminocaproic acid	TABLET;ORAL	209060-002	Nov 27, 2018	AB	RX	No	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Amneal	AMINOCAPROIC ACID	aminocaproic acid	TABLET;ORAL	212492-001	Nov 26, 2019	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.